| | | Single nucleotide variant (missense variant) | Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes | |
| | | Single nucleotide variant (missense variant) | Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes | |
| | | Single nucleotide variant (missense variant) | Neoplasm of uterine cervix +6 more | |
| | | Single nucleotide variant (missense variant) | Carcinoma of esophagus +17 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes +1 more | |
| | | Single nucleotide variant (missense variant) | Inborn genetic diseases +1 more | |
| | | Single nucleotide variant (missense variant) | Carcinoma of esophagus +15 more | |
| | | Single nucleotide variant (missense variant) | Carcinoma of esophagus +16 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Small cell lung carcinoma +26 more | GPathogenic/Likely pathogenic; drug response |
| | | Single nucleotide variant (missense variant) | not provided +6 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Ovarian neoplasm | |
| | | Single nucleotide variant (missense variant) | PIK3CA related overgrowth syndrome | |
| | | Single nucleotide variant (missense variant) | Megalencephaly-capillary malformation-polymicrogyria syndrome +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Connective tissue disorder +17 more | |
| | | Single nucleotide variant (missense variant +2 more) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | Uterine carcinosarcoma +11 more | |
| | | Single nucleotide variant (missense variant) | Uterine carcinosarcoma +11 more | |
| | | Single nucleotide variant (missense variant) | Malignant neoplasm of body of uterus +11 more | |
| | | Single nucleotide variant (missense variant) | Uterine carcinosarcoma +11 more | |
| | | Single nucleotide variant (missense variant) | not provided +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Papillary renal cell carcinoma, sporadic +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Non-small cell lung carcinoma | |
| | | Single nucleotide variant (missense variant) | RASopathy +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided | |
| | | Single nucleotide variant (missense variant) | Malignant neoplasm of body of uterus +3 more | |
| | | Single nucleotide variant (missense variant +2 more) | Familial melanoma +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Malignant tumor of urinary bladder +8 more | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +6 more | |
| | | Single nucleotide variant (missense variant +1 more) | Costello syndrome | |
| | | Single nucleotide variant (missense variant) | not provided +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome 1 +15 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome | |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome +1 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome 1 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome 1 +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome | |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome 1 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Squamous cell carcinoma of the head and neck +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Carcinoma of esophagus +19 more | |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome 1 +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +2 more) | Papillary renal cell carcinoma, sporadic +6 more | |
| | | Indel (missense variant +2 more) | Breast neoplasm +7 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +2 more) | Malignant neoplasm of body of uterus +6 more | |
| | | Single nucleotide variant (missense variant +2 more) | Breast neoplasm +7 more | |
| | | Single nucleotide variant (missense variant) | Papillary renal cell carcinoma, sporadic +2 more | |
| | | Single nucleotide variant (missense variant) | Papillary renal cell carcinoma, sporadic +2 more | |
| | | Single nucleotide variant (missense variant) | Papillary renal cell carcinoma, sporadic +2 more | |